You probably want your doctor to test you with the Mild Behavioural Impairment Checklist (MBI-C) so you know early enough that you need to be doing the Alzheimer prevention protocols you doctor should have for you.
Your chances of getting dementia.
1. A documented 33% dementia chance post-stroke from an Australian study? May 2012.
2. Then this study came out and seems to have a range from 17-66%. December 2013.
3. A 20% chance in this research. July 2013.
4. Dementia Risk Doubled in Patients Following Stroke September 2018
5. Parkinson’s Disease May Have Link to Stroke March 2017
You can't use mine, I'm not medically trained, your doctors are much better; vetted and clinically tested.
Dementia prevention 19 ways per Dean
The latest here:
Researchers identify correlation between MBI(Mild behavioral impairment) and Alzheimer disease
MedicalXpress Breaking News-and-Events | April 09, 2020
In
recent years, scientists have conducted more than 100 clinical trials
in the hopes of finding new indicators capable of diagnosing Alzheimer
disease prior to the manifestation of clinical symptoms such as memory
loss. Though mild behavioral impairment (MBI), characterized by changes
in the normal patterns of behavior in the elderly, had already been
suggested to be an indicator, its role had not yet been validated.
Connection between cognitive and non-cognitive symptoms
In order to verify MBI's association to the early stages of Alzheimer disease, the researchers used imaging techniques to measure amyloid plaque deposits—a protein at the core of Alzheimer disease—in the brains of nearly 100 cognitively healthy elderly individuals with varying degrees of MBI from the Translational Biomarkers in Aging and Dementia (TRIAD) cohort."The unique design of the McGill TRIAD cohort allows young scientist like Firoza to discover the impact of diseases in which specific proteins have become abnormal on human behavior, " says Dr. Pedro Rosa-Neto, Director of the McGill University Research Centre for Studies in Aging.
This is the first time a research team investigates the relationship between MBI and biomarkers of Alzheimer disease in elderly individuals.
"We found that the presence and severity of MBI in these cognitively healthy individuals was strongly associated with the presence of amyloid plaques in the brain, which is one of the first pathological changes in early stages of Alzheimer," says Firoza Lussier, who is a master's student in McGill's Integrated Program in Neuroscience.
Using the MBI as a prediction tool
It has been noted that MBI could potentially serve as an interesting proxy for clinicians to diagnose Alzheimer disease before the onset of symptoms. This could be done with the help of the Mild Behavioural Impairment Checklist (MBI-C), an instrument used to codify mental disorder symptoms attributable to diseases of the nervous system in pre-dementia populations."This is an important study because it may help identify people who are at a higher risk of progression of Alzheimer disease by employing a user-friendly clinical scale developed in Canada by Dr. Zahinoor Ismail, and already available world-wide," adds Dr. Serge Gauthier, Director of the Alzheimer Disease and Related Disorders Research Unit.
Lussier and her colleagues now hope to conduct longitudinal imaging studies to confirm whether MBI is predictive of changes in Alzheimer disease biomarkers.
"Mild behavioral impairment is associated with β-amyloid but not tau or neurodegeneration in cognitively intact elderly individuals" by Firoza Lussier et al. was published in Alzheimer's & Dementia.
To read more, click here.
No comments:
Post a Comment